The NanoDx™ System sensor design features an array of highly sensitive silicon nanowires embedded with biomarker-specific antibodies or receptor molecules. The nanowires measure minute changes in electrical resistance caused by antigens attaching to the antibodies, providing accurate measurement of the target analyte.
Ultra-sensitive nano biosensor delivers lab accuracy at the point of care.
Measures biomarker kinetics in real time, accelerating clinical decision-making.
No sample preparation or reagents required.
Novel nanowire technology enables large-scale production, driving down costs.
Extensible multiplexing capability enables rapid development of new assays.
*The NanoDx™ System has not been evaluated by the FDA or other regulatory agencies.
